Dacomitinib is an Irreversible ERBB Family Inhibitor for Kinds of Cancers Research
Subclass I of the receptor tyrosine kinase (RTK) superfamily consists of the ERBB or epidermal growth factor (EGF) receptors. In humans, the family includes Her1 (EGFR, ERBB1), Her2 (ERBB2), Her3…